Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
05 Februar 2024 - 10:30PM
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal
solutions company, today announced the promotion of Keith Pfeil as
chief operating officer (COO) and chief financial officer (CFO).
Having served as the Company’s CFO since August
2019, in this expanded role, Pfeil will help further drive the
Company's strategic roadmap through business and operational
planning as well as financial performance management. He will
oversee all day-to-day operational activities of the corporation
for successful attainment of yearly business plans, ensuring strong
growth and profit, in addition to overseeing all finance activities
and representing the organization to external stakeholders.
"With a track record of over 20 years of
high-performance industry experience, including the past four years
with Globus, Keith has demonstrated operational and financial
leadership and a deep passion for our business," said Dan Scavilla,
president and chief executive officer of Globus Medical, to whom
Pfeil will continue reporting. "I am confident he will help us
continue to unlock operational efficiency, deliver the next phase
of profitable growth, and ensure a successful transition through
our ongoing integration following our merger with NuVasive, which
continues to progress according to plan."
"I am excited to take on the role of COO in
addition to my current role of CFO, as Globus continues to build on
the momentum we have created to transform our industry and help
change more patient lives around the globe," said Pfeil. "I look
forward to continuing to work with our board of directors, Dan and
the executive leadership team to further realize our growth
potential."
The Company expects to announce its fourth
quarter and full year 2023 financial results on February 20, 2024,
after the market close.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading
musculoskeletal solutions company based in Audubon, PA. The company
was founded in 2003 by an experienced team of professionals with a
shared vision to create products that enable surgeons to promote
healing in patients with musculoskeletal disorders. Additional
information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release
other than statements of historical fact are forward-looking
statements and may be identified by their use of words such as
“believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,”
“continue,” “anticipate,” “intend,” “expect,” “plan” and other
similar terms. These forward-looking statements are based on our
current assumptions, expectations and estimates of future events
and trends. Forward-looking statements are only predictions and are
subject to many risks, uncertainties and other factors that may
affect our businesses and operations and could cause actual results
to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, the risks and costs
associated with the integration of, and our ability to integrate
the NuVasive business successfully and to achieve anticipated
synergies, health epidemics, pandemics and similar outbreaks,
including the COVID-19 pandemic, factors affecting our quarterly
results, our ability to manage our growth, our ability to sustain
our profitability, demand for our products, our ability to compete
successfully (including without limitation our ability to convince
surgeons to use our products and our ability to attract and retain
sales and other personnel), our ability to rapidly develop and
introduce new products, our ability to develop and execute on
successful business strategies, our ability to comply with laws and
regulations that are or may become applicable to our businesses,
our ability to safeguard our intellectual property, our success in
defending legal proceedings brought against us, trends in the
medical device industry, general economic conditions, and other
risks. For a discussion of these and other risks, uncertainties and
other factors that could affect our results, you should refer to
the disclosure contained in our most recent annual report on Form
10-K filed with the U.S. Securities and Exchange Commission,
including the sections labeled “Risk Factors” and “Cautionary Note
Concerning Forward-Looking Statements,” and in our Forms 10-Q,
Forms 8-K and other filings with the U.S. Securities and Exchange
Commission. These documents are available at www.sec.gov. Moreover,
we operate in an evolving environment. New risk factors and
uncertainties emerge from time to time and it is not possible for
us to predict all risk factors and uncertainties, nor can we assess
the impact of all factors on our business or the extent to which
any factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements. Given these risks and uncertainties, readers are
cautioned not to place undue reliance on any forward-looking
statements. Forward-looking statements contained in this press
release speak only as of the date of this press release. We
undertake no obligation to update any forward-looking statements as
a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:Brian KearnsSenior
Vice President, Business Development and Investor RelationsPhone:
(610) 930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Moran ChavezSenior Director, Corporate AffairsPhone: (619)
318-7681Email: media@nuvasive.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/7b929531-d313-486f-9332-315f12d4efb4
Globus Medical (NYSE:GMED)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
Von Mai 2023 bis Mai 2024